FDA.reportPublic FDA data

avapritinib 50 MG Oral Tablet [Ayvakit]

RxCUI
2559729
RxNorm name
avapritinib 50 MG Oral Tablet [Ayvakit]
Display name
avapritinib 50 MG Oral Tablet [Ayvakit]
Full name
avapritinib 50 MG Oral Tablet [Ayvakit]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
645c887c-8cd4-4623-8da9-ac223d71a8b9AYVAKIT 50 MG Oral Tablet [PSN] · avapritinib 50 MG Oral Tablet [Ayvakit] [SBD] · Ayvakit 50 MG Oral Tablet [SY]313These highlights do not include all the information needed to use AYVAKIT safely and effectively. See full prescribing information for AYVAKIT. AYVAKIT ® (avapritinib) tablets, for oral use Initial U.S. Approval: 202020250711